BRIACELL THERAPEUTICS CORP. Tax Expense Income At Applicable Tax Rate
BRIACELL THERAPEUTICS CORP. (BCTX) reported Tax Expense Income At Applicable Tax Rate of -$115.65 thousand for the 12-month period ending 2021-07-31, per its 40-F/A filed 2021-11-16.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate · last filed 2021-11-16
| Period end | Tax Expense Income At Applicable Tax Rate 12 month |
|---|---|
| 2021-07-31 | -$115.65K 40-F/A · filed 2021-11-16 |
| 2020-07-31 | -$1.09M 40-F/A · filed 2021-11-16 |
| 2019-07-31 | -$1.27M 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |